These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6248875)

  • 1. Persistence of increased platelet cyclic AMP induced by prostaglandin E1 after removal of the hormone.
    Sinha AK; Colman RW
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2946-50. PubMed ID: 6248875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding to prostaglandin (PG) receptors and activation of adenyl cyclase by 20-isopropylidene-PGS in rabbit platelet membranes.
    Ushiyama S; Handa S; Yamazaki M
    Prostaglandins; 1988 Oct; 36(4):477-89. PubMed ID: 2853419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
    Jaschonek K; Renn W; Weisenberger H
    Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1988 Oct; 972(1):45-53. PubMed ID: 2902882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of prostaglandin E1 binding to human blood platelet membrane by insulin and the activation of adenylate cyclase.
    Kahn NN; Sinha AK
    J Biol Chem; 1990 Mar; 265(9):4976-81. PubMed ID: 1969414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationships between Ca2+ and adenylate and guanylate cyclases in the control of platelet secretion and aggregation.
    Rodan GA; Feinstein MB
    Proc Natl Acad Sci U S A; 1976 Jun; 73(6):1829-33. PubMed ID: 6960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of genes for metabolism of cyclic adenosine 3':5'-monophosphate in somatic cells. beta-Adrenergic and PGE1 receptors in parental and hybrid cells.
    Brunton LL; Maguire ME; Anderson HJ; Gilman AG
    J Biol Chem; 1977 Feb; 252(4):1293-302. PubMed ID: 190227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.
    Harris DN; Asaad MM; Phillips MB; Goldenberg HJ; Antonaccio MJ
    J Cyclic Nucleotide Res; 1979; 5(2):125-34. PubMed ID: 221552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization of prostaglandin-activated platelet adenylate cyclase.
    Cooper B; Schafer AI; Puchalsky D; Handin RI
    Prostaglandins; 1979 Apr; 17(4):561-71. PubMed ID: 461820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP independent inhibition of platelet aggregation by prostaglandin E1 is mediated through factor Xa.
    Sinha AK; Colman RW
    Thromb Res; 1983 Jun; 30(6):553-64. PubMed ID: 6310817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
    Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
    Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical evidence for PGI2 and PGE2 receptors in the rabbit renal preglomerular microvasculature.
    Chaudhari A; Gupta S; Kirschenbaum MA
    Biochim Biophys Acta; 1990 Jul; 1053(2-3):156-61. PubMed ID: 2166584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenylate cyclase from synchronized neuroblastoma cells: responsiveness to prostaglandin E1, adenosine, and dopamine during the cell cycle.
    Pénit J; Cantau B; Huot J; Jard S
    Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1575-9. PubMed ID: 266197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
    Williams KA; Murphy W; Haslam RJ
    Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (5Z)-carbacyclin discriminates between prostacyclin-receptors coupled to adenylate cyclase in vascular smooth muscle and platelets.
    Corsini A; Folco GC; Fumagalli R; Nicosia S; Noe MA; Oliva D
    Br J Pharmacol; 1987 Jan; 90(1):255-61. PubMed ID: 3545351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.